Pharmaceutical Investing EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress
Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone
High Grade surface silver results up to 920g/t Ag recorded ~300m to the north and ~150m to the south of Elizabeth Hill mineralisation
